US - NIH: COVID-19 Treatment Guidelines - April 21, 2020

[sharon sanders]

Appendix A, Table 1. COVID-19 Treatment Guidelines Panel Members

Roy M. Gulick, MD	Weill Cornell Medicine, New York, NY
H. Clifford Lane, MD	National Institutes of Health, Bethesda, MD
Henry Masur, MD	National Institutes of Health, Bethesda, MD
Alice K. Pau, PharmD	National Institutes of Health, Bethesda, MD
Judith Aberg, MD	Icahn School of Medicine at Mount Sinai, New York, NY
Adaora Adimora, MD	UNC School of Medicine, Chapel Hill, NC
Jason Baker, MD	Hennepin Healthcare/University of Minnesota, Minneapolis, MN
Roger Bedimo, MD	University of Texas Southwestern/VA North Texas Health Care System, Dallas, TX
Stephen Cantrill, MD	Denver Health, Denver, CO
Ann C. Collier, MD	University of Washington, Seattle, WA
Craig Coopersmith, MD	Emory University School of Medicine, Atlanta, GA
Eric Daar, MD	Harbor-UCLA Medical Center, Torrance, CA
Susan L. Davis, PharmD	Wayne State University, Detroit, MI
Amy L. Dzierba, PharmD	New York-Presbyterian Hospital, New York, NY
Laura Evans, MD	University of Washington, Seattle, WA
Rajesh Gandhi, MD	Massachusetts General Hospital/Harvard Medical School, Boston, MA
David Glidden, PhD	University of California San Francisco, San Francisco, CA
Birgit Grund, PhD	University of Minnesota, Minneapolis, MN
Erica J. Hardy, MD	Warren Alpert Medical School, Brown University, Providence, RI
Brenna L. Hughes, MD	Duke University School of Medicine, Chapel Hill, NC
Steven Johnson, MD	University of Colorado School of Medicine, Aurora, CO
Marla J. Keller, MD	Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
Arthur Kim, MD, PhD	Massachusetts General Hospital/Harvard Medical School, Boston, MA
Jeffrey L. Lennox, MD	Emory University School of Medicine, Atlanta, GA
Mitchell M. Levy, MD	Warren Alpert Medical School, Brown University, Providence, RI
Gregory Martin, MD	Emory University School of Medicine, Atlanta, GA
Susanna Naggie, MD	Duke University School of Medicine, Durham, NC
Steven Q. Simpson, MD	University of Kansas Medical Center, Kansas City, KS
Susan Swindells, MD	University of Nebraska Medical Center, Omaha, NE
Pablo Tebas, MD	University of Pennsylvania, Philadelphia, PA
Phyllis Tien, MD	University of California San Francisco, San Francisco, CA
Alpana A. Waghmare, MD	Seattle Children’s Hospital, Seattle, WA
Kevin C. Wilson, MD	Boston University School of Medicine, Boston, MA
Timothy Burgess, MD	Department of Defense, Bethesda, MD
Joseph Francis, MD	Department of Veterans Affairs, Washington, DC
Virginia Sheikh, MD	Food and Drug Administration, Silver Spring, MD
Timothy Uyeki, MD	Centers for Disease Control and Prevention, Atlanta, GA
Robert Walker, MD	Biomedical Advanced Research and Development Authority, Washington, DC
Pamela Belperio, PharmD	Department of Veterans Affairs, Los Angeles, CA
John T. Brooks, MD	Centers for Disease Control and Prevention, Atlanta, GA
Richard T. Davey, Jr., MD	National Institutes of Health, Bethesda, MD
Laurie K. Doepel	National Institutes of Health, Bethesda, MD
Robert W. Eisinger, PhD	National Institutes of Health, Bethesda, MD
Elizabeth S. Higgs, MD	National Institutes of Health, Bethesda, MD
Martha C. Nason, PhD	National Institutes of Health, Bethesda, MD
Nitin Seam, MD	National Institutes of Health, Bethesda, MD
Kanal Singh, MD	National Institutes of Health, Bethesda, MD
Page Crew, PharmD	National Institutes of Health, Bethesda, MD
Safia Kuriakose, PharmD	Leidos Biomedical Res, Inc., in support of NIAID, Frederick, MD
Andrea M. Lerner, MD	National Institutes of Health, Bethesda, MD

https://www.covid19treatmentguidelin.../panel-roster/